The treatment of tuberculosis requires daily intake of multiple medications for between 6
months and 2 years, or more [1, 2]. This long duration predisposes to the interruption of …

TB incidence and mortality in Belarus has been progressively falling from 54 to 41 and from
12.1 to 6.8 per 100000, accordingly, for the last 7 years. Nevertheless, the number of HIV/TB …

Background: In Belarus, care for multidrug-resistant tuberculosis (strains resistant to at least
isoniazid and rifampicin, MDR-TB) patients has been effectively implemented since 2008. …

Outcomes of treatment for multidrug-resistant tuberculosis (MDR-TB) remain poor worldwide.
In MDR-TB patients starting treatment in 2012 in Belarus, only 54% completed it …

Background: Practical Approach to Lung Health (PAL) is a patient-centred approach to improving
the quality of diagnosis and treatment of common respiratory illnesses (including TB) in …

Background: In Gomel, a region in south-east Belarus (country population 9.5 million in 2011;
Gomel 1.5 million), TB patients with strains resistant to at least isoniazid and rifampicin (…

Tuberculosis (TB) strains with rifampicin-resistance (RR-TB) and multidrug-resistance (RR-TB
plus resistance to isoniazid; MDR-TB) are less amenable to treatment than drug-…

Observational data from MDR-TB high burden countries on the outcome of MDR-TB in HIV
positive populations remain sparse. In terms of MDR-TB and HIV TB co-infection Gomel …

Ensuring that patients adhere to prescribed medication remains an important challenge in
global health. While technology has been utilized to monitor and improve adherence, …

Scaling-up collaborative tuberculosis and human immunodeficiency virus (TB/HIV) activities
in the WHO European region is a priority. The region accounts for 6% of the global burden …